noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Synaptics Incorporated

Statement of Changes in Beneficial Ownership (Form 4)
Lisa Blunt Rochester

NEWS: Senate Passes Resolution Honoring the Late Reverend Jesse[...]
Commonwealth of Pennsylvania

ADVISORY - CUMBERLAND COUNTY - Shapiro Administration Announces Funding[...]

Healthcare

Catalyst Pharmaceuticals Inc.

03/18/2026 | Press release | Distributed by Public on 03/18/2026 15:15

Material Event (Form 8-K)

Item 8.01

Other Events

On March 18, 2026, the District Court for the District of New Jersey filed an order delaying the start of the bench trial between the Company and Hetero USA, Inc. from March 23, 2026 until May 18, 2026. The bench trial relates to the validity of the Company's Orange Book-listed patents related to FIRDAPSE^® that expire in 2032, 2034, and 2037.

Catalyst Pharmaceuticals Inc. published this content on March 18, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 18, 2026 at 21:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]